Horn & Co advised Vascular Biogenics Ltd on the deal.
Vascular Biogenics Ltd. raised an additional $8.1 million, completing an aggregate $18.1 million raise.
Vascular Biogenics Ltd. is a clinical stage biotechnology company engaged in the discovery, development, and commercialization of novel treatments for cancer and immune-inflammatory diseases.
The Horn & Co team was led by Yuval Horn (Picture), Keren Kanir and Shimrit Roznek.
Law Firms: Horn & Co. Law;
Clients: Vascular Biogenics Ltd.;